InsideTrading SEC Form 4 insider trades

Stocks

XLO Xilio Therapeutics, Inc.

Healthcare · Market cap: $46.7M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $4.2K 2024-Q2: bought $368.8K, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $1.8M, sold $0 2025-Q1: bought $0, sold $8.6K 2025-Q2: bought $73.0K, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $0, sold $0 2026-Q1: bought $43.9K, sold $5.7K 2026-Q2: bought $0, sold $0 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $1.8M) Sold, below the line (largest quarter $8.6K)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$0
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$4.2K
2024-Q2$368.8K$0
2024-Q3$0$0
2024-Q4$1.8M$0
2025-Q1$0$8.6K
2025-Q2$73.0K$0
2025-Q3$0$0
2025-Q4$0$0
2026-Q1$43.9K$5.7K
2026-Q2$0$0
2026-Q3$0$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$2.7M9 buy days
Sold$18.5K7 sell days
Net insider flow+$2.7Mnet buying · 5 years
Latest trade2026-03-26Shannon James Samuel
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-03-26 Buy Shannon James Samuel Director 5,000 $8.79 $43.9K 1
2026-01-02 Sell Frankenfield Christopher James CFO 7,030 $0.64 $4.5K 1
2026-01-02 Sell Brennan Kevin M. EVP / SVP 1,826 $0.64 $1.2K 1
2025-06-17 Buy Shannon James Samuel Director 25,000 $0.69 $17.2K 1
2025-06-16 Buy Shannon James Samuel Director 45,000 $0.69 $31.0K 1
2025-06-16 Buy Russo Rene CEO 36,289 $0.68 $24.7K 1
2025-01-02 Sell Frankenfield Christopher James CFO 6,954 $0.98 $6.8K 1
2025-01-02 Sell Brennan Kevin M. EVP / SVP 1,803 $0.98 $1.8K 1
2024-12-18 Buy GILEAD SCIENCES, INC. 10% owner 1,759,978 $1.04 $1.8M 1
2024-04-02 Buy GILEAD SCIENCES, INC. 10% owner 485,250 $0.76 $368.8K 1
2024-02-08 Sell Atlas Venture Fund XI, L.P. 10% owner 1,000 $0.64 $640 2
2024-01-12 Sell Atlas Venture Fund XI, L.P. 10% owner 2,100 $0.83 $1.7K 2
2024-01-11 Sell Atlas Venture Fund XI, L.P. 10% owner 2,135 $0.87 $1.9K 2
2021-12-10 Buy BCIP Life Sciences Associates, LP 10% owner 25,000 $9.65 $241.2K 2
2021-12-09 Buy BCIP Life Sciences Associates, LP 10% owner 4,011 $9.84 $39.5K 1
2021-12-08 Buy BCIP Life Sciences Associates, LP 10% owner 13,458 $9.62 $129.5K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
GILEAD SCIENCES, INC. 10% owner $2.2M $0 2024-12-18
BCIP Life Sciences Associates, LP 10% owner $410.1K $0 2021-12-10
Shannon James Samuel Director $92.2K $0 2026-03-26
Russo Rene CEO $24.7K $0 2025-06-16
Frankenfield Christopher James CFO $0 $11.3K 2026-01-02
Atlas Venture Fund XI, L.P. 10% owner $0 $4.2K 2024-02-08
Brennan Kevin M. EVP / SVP $0 $2.9K 2026-01-02

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2021-10-26 6 $36.2M 50 +21.0% (+21.6% raw)-7.4% (-12.6% raw)-71.0% (-76.6% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.